Alpha-2 adrenoceptor activity affects propofol-induced sleep time

Anesthesia and Analgesia

Volumn 94, Issue 5, 2002, Pages 1201-1206

  Kushikata, Tetsuya ^a   Hirota, Kazuyoshi ^a   Yoshida, Hitoshi ^a   Kubota, Takeshi ^a   Ishihara, Hironori ^a   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; NORADRENALIN; PROPOFOL; YOHIMBINE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RAT STRAIN; SLEEP; SLEEP TIME;

EID: 0036241734     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200205000-00028     Document Type: Article

References (27)

1. Anaesthesia: The role of adrenergic mechanisms
2. Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems
3. Chronic and acute administration of typicaland atypical antidepressants on activity of brain noradrenalinesystems in the rat thiopentone anaesthesia model
4. Effects of ketamine andpentobarbital on noradrenaline release from the medial prefrontal cortex in rats
5. Effects of sedatives onnoradrenaline release from the medial prefrontal cortex in rats
6. Inhibitory effect ofclonidine on ketamine-induced norepinephrine release from themedial prefrontal cortex in rats
7. Effects of two volatileanesthetics (sevoflurane and halothane) on the hypothalamicnoradrenaline release in rat brain
8. Possible involvement of alpha2-adrenoceptor on the hypnotic action of flunitrazepam
9. Brain noradrenaline andanaesthesia: Behavioral and electrophysiological evidence
10. Xenon inhalationincreases norepinephrine release from the anterior and posteriorhypothalamus in rats
11. Presynaptic regulation of the release of catecholamines
12. Molecular pharmacologyof alpha 2-adrenoceptor subtypes
13. Gene targeting-homingin on alpha 2-adrenoceptor-subtype function
14. In vivo gene modificationelucidates subtype-specific functions of alpha(2)-adrenergic receptors
15. Distribution and pharmacology ofalpha 2-adrenoceptors in the central nervous system
16. Alpha-2 and imidazolinereceptor agonists: Their pharmacology and therapeutic role
17. Evaluation ofthe effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine
18. Interactions of intravenousanesthetics with cerebral alpha-2-adrenoceptors
19. Actions of the hypnotic anaesthetic,dexmedetomidine, on noradrenaline release and cell firing in ratlocus coeruleus slices
20. A comparisonbetween medetomidine-ketamine and medetomidine-propofolanaesthesia in rabbits
21. Biochemical and electrophysiologic evidence that propofol enhances GABAergictransmission in the rat brain
22. Propofol anaesthesiain mice is potentiated by muscimol and reversed by bicuculline
23. Clonidine enhances the release of endogenous gamma-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebralcortex subregions
24. Inhibition by yohimbine of thecalcium-dependent evoked release of [3H]GABA in rat andmouse brain slices in vitro
25. Enhancement of endogenous GABA release from rat synaptosomal preparations is mediated by alpha 2-adrenoceptors pharmacologically differentfrom alpha 2-autoreceptors